Hongxin Zhou
Key Laboratory Of Carcinogenesis And Cancer Invasion
Zhongshan, 200032, China
Zhongshan, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction to "In Vivo Interrogation of Cell-Penetrating Peptide Function: Accumulation in Tumors and the Potential as a Specific PET Probe".
Journal: Bioconjugate chemistry
Published: February 20, 2026
In Vivo Interrogation of Cell-Penetrating Peptide Function: Accumulation in Tumors and the Potential as a Specific PET Probe.
Journal: Bioconjugate chemistry
Published: April 09, 2025
Aptamer-based nanoparticle drug delivery system designed for targeting GPC3-positive liver cancer.
Journal: Journal of pharmaceutical analysis
Published: March 10, 2025
Aptamers: Promising Reagents in Biomedicine Application.
Journal: Advanced biology
Published: December 05, 2023
miR-612 Enhances RSL3-Induced Ferroptosis of Hepatocellular Carcinoma Cells via Mevalonate Pathway.
Journal: Journal of hepatocellular carcinoma
Published: August 01, 2023
AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation.
Journal: Clinical and translational medicine
Published: July 30, 2020
A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma.
Journal: International journal of nanomedicine
Published: August 21, 2018
Phosphorothioate-Modified AP613-1 Specifically Targets GPC3 when Used for Hepatocellular Carcinoma Cell Imaging.
Journal: Molecular therapy. Nucleic acids
Published: August 12, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026